(GCPL) have rebounded ~7% in the past two sessions following its Q4FY26 business update. While margin pressures from elevated palm oil prices remain a concern, management’s guidance on cost mitigation and sustained growth across categories has reassured investors.
Margins & Cost Outlook
- Palm oil at MYR 4,500–4,800/tonne and Brent crude at $100–110/barrel imply a 6–9% cost hit in FY27.
- GCPL plans to offset this via price hikes, cost savings, and media optimization.
- Management expects to remain broadly in line with FY27 bottom-line plans while stepping up revenue growth.
- Q4FY26 standalone EBITDA margin expected to sustain within 24–26% normative range.
Segmental Performance
- Home Care (45% of India sales): Nomura expects near double-digit growth; household insecticides in high single digits; new/growth businesses >15%.
- Personal Care: mid-single-digit growth; soaps restocking benefit fading, but hair colours and deos in high single digits.
- GAUM (Africa, US, Middle East): continues double-digit growth, skewed toward faster-growth categories like hair care and insecticides.
- Excluding soaps, Q4 volume growth remains in double digits.
Financials
- Q4FY26 consolidated revenue expected to rise almost double-digit YoY, slightly ahead of expectations.
- 9MFY26 consolidated revenue grew 7.6% YoY.
- Q4 EBITDA growth expected to be in line with revenue growth.
Valuation & Risks
- Stock trades at 38x FY28E earnings (Bloomberg consensus).
- Elevated costs could accelerate formalization of demand in select categories.
- Risks: sharper-than-expected input cost spikes or delays in price hikes could temporarily compress margins due to lag effects.
Conclusion
GCPL’s Q4 update highlights resilience across geographies and categories, with strong contributions from home care and GAUM markets. Despite cost headwinds, price hikes, mix improvement, and growth in high-potential categories position the company for sustained revenue expansion in FY27.